Metformin Pill G7: Imprint & Dosage Guide | MedicineBD

✨ This article was AI edited. Editorial responsibility: MedicineBD.net.

Pill Identification & Physical Characteristics of G7

Proper identification of prescription oral medications protects patients from dosing errors and counterfeit ingestion. The white round tablet imprinted with G7 possesses specific pharmaceutical physical attributes registered with the US National Library of Medicine (DailyMed):

• Imprint: “G7” debossed on one side, plain / unprinted on the reverse side.
• Color: White to off-white.
• Shape: Round, biconvex, film-coated tablet.
• Score Line: Unscored (smooth edges).
• Active Ingredient: Metformin Hydrochloride, 500 mg.
• Drug Class: Biguanide oral antihyperglycemic.
• National Drug Code (NDC): 70010-001-01 (100 count bottle), 70010-001-05 (500 count bottle), 70010-001-10 (1000 count bottle).
• Manufacturer: Granules India Limited (Gagillapur unit, Hyderabad, India).
• US Labeler / Distributor: Granules Pharmaceuticals Inc.

Comprehensive Pill Identification Table: G7 vs. Other Common Metformin Imprints

Clinical Indications & Mechanism of Action

The G7 500 mg metformin tablet is prescribed as an adjunct to diet and exercise to lower blood glucose concentrations in adults and children 10 years of age and older with type 2 diabetes. Its antihyperglycemic effects stem from three coordinated mechanisms:

1. Decreases Hepatic Glucose Synthesis: Reduces excessive glucose output by the liver via transient mitochondrial respiratory chain complex I inhibition and AMPK enzyme activation.
2. Enhances Peripheral Insulin Sensitivity: Increases glucose uptake and utilization in skeletal muscle cells by translocating GLUT4 glucose transporters.
3. Slows Intestinal Glucose Absorption: Decreases the rate of carbohydrate absorption across the intestinal mucosal brush border.

Dosage Administration & Titration Rules for G7 (500mg IR)

Because G7 is an Immediate-Release tablet, strictly follow these administration guidelines:

• Take With Food: Always swallow your G7 tablet with or immediately after a meal (e.g., breakfast or dinner). Taking metformin on an empty stomach dramatically increases the incidence of nausea, vomiting, and explosive watery diarrhea.
• Standard Initiation Regimen: Take one 500 mg G7 tablet orally once daily with dinner for the first 7 days, then increase to one 500 mg tablet twice daily (with breakfast and dinner).
• Maintenance Titration: If additional glycemic control is required, your physician may increase the dose in 500 mg increments every 1 to 2 weeks up to a maximum daily ceiling of 2,550 mg per day (e.g., one 850mg tablet three times daily or five 500mg tablets in divided doses).

Inactive Excipients & Allergen Information

In addition to 500 mg of pure metformin hydrochloride, each G7 tablet contains standard pharmaceutical inactive ingredients:

• Povidone (K-30 binder)
• Magnesium stearate (lubricant)
• Hypromellose (film coating agent)
• Polyethylene glycol (plasticizer)
• Titanium dioxide (white opacifier)

G7 tablets are gluten-free, sugar-free, and contain zero tartrazine or animal gelatin.

Frequently Asked Questions (FAQ)

Storage Conditions & Safe Handling Guidelines

Store your G7 metformin 500 mg tablets at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep tablets in their original tightly closed amber container protected from excess humidity, heat, and direct sunlight. Avoid storing tablets in humid bathroom cabinets where steam can degrade the film coating. Keep out of reach of children and pets.